George M. Milne, Jr., Vice Chair

Biotech Investor

Photo of George M. Milne, Jr.


  • Ph.D., Organic Chemistry, MIT
  • B.S., Chemistry, Yale University

Dr. Milne is a biotech investor and board member. Prior to his recent position as a venture partner at Radius Ventures, Dr Milne worked for more than 30 years at Pfizer in various executive capacities, most recently as president of Pfizer Central Research with global responsibility for human and animal health research and development.

He has served on the Board of Directors at many different companies and organizations including currently Aurinia Pharmaceuticals, Amylyx Pharmaceuticals, Charles River Laboratories, Draper Laboratory (advisor to the Board), Gaylord Hospital, The Sea Research Foundation, and The New York Botanical Garden. With his long tenure at Pfizer, his work at Radius as a venture partner and his service on multiple life sciences boards, Dr. Milne has a broad understanding of R&D processes and the services, tools and technologies being used in the life sciences arena and the important role of innovation in advancing human health.

Milne holds a BSc from Yale and a PhD from the Massachusetts Institute of Technology. He is married and has two grown sons.